Prediction of Long-term Outcome in Aortic Stenosis After Valve Intervention
Condition(s) studied
Investigational drug(s) / intervention(s)
There is no intervention since it is an observational study patients are treated according to clinical praxis: No intervention
Study summary
Patients with severe aortic stenosis accepted for transcatheter intervention or open surgery are included before the intervention, and then followed up with clinical visits during the first year after intervention. Imaging with echocardiography and computed tomography (CT) are performed together with additional imaging with magnetic resonance imaging (MRI) and Positron emissions tomography (PET)-CT in a subgroup of the study population. Blood samples, physical performance and questionnaires with focus on frailty and heart failure are also collected at each visit. A follow up with information of the outcomes after 2-5 years will be performed through national registries.
Eligibility
Primary outcome measure(s)
- Semiquantitative assessment of protein levels associated with myocardial performance — One year after intervention.
Level of normalized protein expression (NPX) in plasma, assessed by a multiplex proximity extension assay panel (Olink Bioscience, Uppsala, Sweden). - Imaging parameters associated with clinical outcome after intervention — One year after intervention
Global longitudinal strain (%) of the right and left ventricle. The clinical outcome defined as a combination of mortality and hospitalization of heart failure - Semiquantitative assessment of protein levels associated with myocardial performance associated with clinical outcome after intervention — Two years after intervention
Level of normalized protein expression (NPX) in plasma, assessed by a multiplex proximity extension assay panel (Olink Bioscience, Uppsala, Sweden). The clinical outcome defined as a combination of mortality and hospitalization for heart failure.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of cardiology Uppsala University Hospital | Uppsala | Sweden | Recruiting |
More Uppsala University trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05629104 on ClinicalTrials.gov ↗ ← All trials in Sweden